Physician profile
Dan G Tom
NPI 1801931647
$4,095.25
in general payments reported to CMS, 2019-2025
17 companies · $869 in 2025
The $869 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $19.40 · 2022: $494 · 2023: $1,188 · 2024: $823 · 2025: $869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,565 · Entertainment: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,565.15 |
| Entertainment | $315.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $910.04 | 2022-2025 | Infuse, Miebo |
| Alcon Vision LLC | $564.21 | 2019-2025 | Precision7, Total30, Precision 1 |
| Optos, INC. | $443.48 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $361.33 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $315.45 | 2019 | |
| Coopervision INC. | $246.30 | 2019-2023 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $203.69 | 2025 | |
| Abbvie INC. | $125.00 | 2022 | |
| Sight Sciences, INC. | $124.95 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $123.41 | 2023 | |
| Astellas Pharma US INC | $121.86 | 2025 | Izervay |
| Oyster Point Pharma, INC. | $121.16 | 2023 | Tyrvaya |
| Dompe US, INC. | $120.85 | 2024 | Oxervate |
| Abb Con-Cise Optical Group LLC | $114.15 | 2023 | Contact Lens, Spectacle Lenses |
| Harrow Eye, LLC | $98.55 | 2025 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $81.42 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Tom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.